The role of ICAM-1 and a number of clinical and morphological factors in the development of tubulointerstitial fibrosis in chronic glomerulonephritis


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Today, it is known that all patients with chronic kidney disease have a progressive decrease in renal function over time due to the formation of tubulo-interstitial fibrosis. At present, it has been established that endothelial dysfunction (Ed) is formed long before the detection of sclerosis in the renal tissue, and exerts its influence on the development of various clinical and morphological manifestations of chronic glomerulonephritis. The intercellular adhesion molecule - 1 (IСАМ-1), involved in the processes of renal inflammation, is one of the factors of Ed. For this reason, the search for non-invasive methods for assessing the state of the renal tissue, including the identification of proteins involved in the processes of renal inflammation, fibrosis, and cell-cell interaction, becomes relevant as it will prevent or delay the progression of a decrease in renal function. Objective. Determination of the blood intercellular adhesion molecule-1 (ICAM-o concentration in conjunction with the clinical and morphological manifestations of chronic glomerulonephritis in the development of tubulo-interstitial fibrosis (TIF) in chronic glomerulonephritis (CGN). Material and methods. Eighty patients with CGN in the acute stage underwent a detailed clinical and laboratory examination, which included determination of the serum ICAM-1 level by enzyme immunoassay, and puncture kidney biopsy with subsequent morphological examination. Statistical analysis was performed using Microsoft Office Excel 2010 (Microsoft Corp., USA) and Statistica 10.0 (StatSoft Inc., USA). Results. a logistic regression analysis to access the impact of ICAM-1 in conjunction with clinical and morphological manifestations on the probability of detection of TIF in the biopsy specimen was carried out. As a result, it was revealed that such clinical and morphological signs as the blood albumin level, narrowing of the arteriole lumen, sclerosis of the glomeruli, along with an increased ICAM-i (Intercellular Adhesion Molecule i) level are factors for the development of TIF. In addition, based on the obtained equations of logistic regression, nomograms to predict the probability of detecting TIF in the kidney biopsy specime were calculated. Conclusion. The results of the study demonstrate the important role of ICAM-1 in the process of development of immunocomplex inflammation in glomerulonephritis and, as a result, increase the risk of developing TIF.

Full Text

Restricted Access

About the authors

K. M Bayandurova

Rostov State Medical University of the Ministry of Health of the Russian Federation

Email: karina1611994@gmal.com
Resident Physician at the Department of Internal Diseases № 2 Rostov-on-Don, Russia

M. M Batyushin

Rostov State Medical University of the Ministry of Health of the Russian Federation

Email: batjushin-m@rambler.ru
Professor at the Department of Internal Diseases № 2 Rostov-on-Don, Russia

I. V Sarvilina

Medical Center "Novomedicina"

Email: isarvilina@mail.ru
Doctor of Medical Sciences Rostov-on-Don, Russia

N. V Antipova

Rostov Regional Clinical Hospital № 2

Email: ob2p@mail.ru
PhD in Medical Sciences, Nephrologist Rostov-on-Don, Russia

E. A Sinelnik

Rostov Regional Clinical Hospital № 2

Email: ob2p@mail.ru
Pathologist Rostov-on-Don, Russia

References

  1. Bello A.K., Levin A., Tonelli M., Okpechi I.G., Feehally J., Harris D., et al. Assessment of Global Kidney Health Care Status. JAMA. 2017; 317(18): 1864- 1919. doi: 10.1001/jama.2017.4046.
  2. Taylor D.M., Fraser S.D.S., Bradley J.A., et al. A systematic review of the prevalence and associations of limited health literacy in CKD. Clin. J. Am. Soc. Nephrol. 2017; 12(7): 1070-1084. doi: 10.2215/CJN.12921216.
  3. Saran R, Robinson B, et al. United States Renal Data System, 2017, Annual data report: An overview of the epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 2018; 71(3S1): A7. doi: 10.1053/j.ajkd.2018.01.002.
  4. Агранович Н.В., Кнышова С.А, Батюшин М.М, Байда А.П. Хроническая болезнь почек в амбулаторно-поликлинической практике. Диагностика, лечение, профилактика, медико-социальная экспертиза. Ставрополь, 2014. С. 46-57.
  5. Агранович Н.В. Обоснование и эффективность профилактики и лечения больных с хронической болезнью почек в амбулаторно-поликлинических условиях. Нефрология. 2013; 17(5): 43-48.
  6. Левицкая Е.С., Батюшин М.М., Пасечник Д.Г., Антипова Н.В. Прогнозирование ремоделирования ткани почек с учетом структурных изменений почечных артерий малого диаметра. Нефрология. 2016; 5: 55-61.
  7. Гасанов М.З., Батюшин М.М., Терентьев В.П., Садовничая Н.А. Протеомный спектр мочи пациентов с хроническим гломерулонефри-том. Клин. нефрология. 2012; 5-6: 28-32.
  8. Шестакова М.В., Дедов И.И. Сахарный диабет и хроническая болезнь почек: Медицинское Информационное Агентство, 2009. [Shestakova M.V., Dedov I.I. Diabetes Mellitus and Chronic Kidney Disease: Medical Information Agency, 2009.
  9. Смирнов А.В., Петрищев Н.Н., Панина И.Ю., Мнускина М.М. и др., Уровень эндотелина-1 и реактивность сосудов микроциркуляторного русла кожи у больных на ранних стадиях хронической болезни почек. Тер. архив. 2011; 83(6): 13-15.
  10. Харламова У.В., Ильичева О.Е. Состояние эндотелиальной функции и системы гемостаза и больных на гемодиализе. Нефрология. 2010; 14(4): 48-52.
  11. Deanfield J.E., Halcox J.P., Rabelink T.J., Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 15: 12-18. Doi: 10,1161/CIRCULATI0NAHA.106.652859.
  12. Kristiansen O.P., Mandrup-Poulsen T. Interleukin-6 and Diabetes the good, the bad, or the indifferent? Diabetes. 2005; (2): 114-124.
  13. Mihout F., Shweke N., Bige N., et al. Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-b1 syntesis. J. Pathol. 2011; 223: 37-45. doi: 10.1002/path.2769.
  14. Zoccali C. Endothelial dysfunction in CKD: a new player in town? Nephrol. and Dialys. 2008; 23(3): 783-785. Doi: https://doi.org/10.1002/path.2769.
  15. Norman J.T., Clark I.M., Garcia P.L., Hypoxia promotes fibrogenesis in human renal fibroblasts, Kidney Int. 2000; 58(6): 2351-2366. Doi: https://doi.org/10.1046/j.1523-1755.2000.00419.x
  16. Attalah M.F., Adel L.A., Fahmy D.E. Diagnostic and prognostic values of adhesion molecules VCAM-1, ICAM-1 and C-reactive protein in Egyptian patients with chronic kidney disease. Egypt. J. Immunol. 2011; 18(2): 59-66.
  17. Kido Y., Ogawa D., Shikata K., Sasaki M., et al., Intercellular adhesion molecule-1 plays a critical role in glomerulosclerosis after subtotal nephrectomy.Clin. Exp. Nephrol. 2011; 15(2): 212-219.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies